JNJ · Business segments
Johnson & Johnson (JNJ) revenue by segment
Where Johnson & Johnson’s revenue comes from, as reported in its SEC filings.
Latest quarter: September 27, 2026
Total revenue on the income statement: $25.4B.
Revenue by Geography
| Line | Revenue | Share |
|---|---|---|
| United States | $14.96B | 58.9% |
| Europe | $5.41B | 21.3% |
| Asia Pacific, Africa | $3.65B | 14.4% |
| Western Hemisphere, excluding U.S. | $1.39B | 5.5% |
Revenue by Segment
| Line | Revenue | Share |
|---|---|---|
| Innovative Medicine | $16.76B | 66.0% |
| MedTech | $8.64B | 34.0% |
Latest year: December 28, 2025
Total revenue on the income statement: $94.19B.
Revenue by Geography
| Line | Revenue | Share |
|---|---|---|
| United States | $53.75B | 57.1% |
| Europe | $21.54B | 22.9% |
| Asia Pacific, Africa | $14.03B | 14.9% |
| Western Hemisphere, excluding U.S. | $4.88B | 5.2% |
Revenue by Segment
| Line | Revenue | Share |
|---|---|---|
| Innovative Medicine | $60.4B | 64.1% |
| MedTech | $33.79B | 35.9% |
Reading notes
Share is each line’s part of that breakdown. Margin is the company’s reported segment operating income divided by that segment’s revenue. Companies define segment profit differently and may re-cut segments over time, so a company’s lines can differ between years. Breakdowns that do not add up to within 5% of reported revenue are left out.